Reproductive Potential and Outcomes in Patients with Hidradenitis Suppurativa: Clinical Profile and Therapeutic Implications

• Main Authors: Trinidad Montero-Vilchez, Luis Salvador-Rodriguez, Andrea Rodriguez-Tejero, Manuel Sanchez-Diaz, Salvador Arias-Santiago, Alejandro Molina-Leyva
• Format: Article
• Language: English
• Published: MDPI AG 2021-03-01
• Series: Life
• Subjects: hidradenitis suppurativa; acne inversa; pregnancy; reproductive behavior
• Online Access: https://www.mdpi.com/2075-1729/11/4/277

There are scarce data available regarding the impact of hidradenitis suppurativa (HS) on fertility, course and outcome of pregnancy and risk associated with treatments. The aims of this study are (1) to describe the clinical profile of HS women of childbearing age with and without accomplished reproductive desires and (2) to describe the prescribed treatments based on the fulfillment of reproductive intentions. We conducted a prospective observational study that included 104 HS women of childbearing age, 50.96% (53/104) with unfulfilled reproductive desires. These women were younger (29.08 vs. 42.06 years, <i>p</i> < 0.001), less frequently married and higher educated than women with fulfilled reproductive desires. Their age of disease onset was lower, but disease duration was shorter, in concordance with a lower International Hidradenitis Suppurativa Severity Score System (IHS4) and lower number of draining tunnels. Combined oral contraceptives were more frequently prescribed in women with unfulfilled reproductive desires (30.19% vs. 9.80%, <i>p</i> = 0.013) while biologics were less used in this group (3.77% vs. 13.73%, <i>p</i> = 0.08). In conclusion, a higher educational level and an earlier disease onset, with potential implications in finding a partner, may make the fulfillment of reproductive desires difficult for patients with HS. This study could help clinicians to achieve a better understanding of the specific characteristics of HS during childbearing age and consider reproductive desires when making treatment decisions.